aegerion pharmaceuticals inc
(AEGR:NASDAQ GS)
Last $60.27 USD
Change Today +0.155 / 0.26%
Volume 107.0K
AEGR On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 11:25 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
Insiders at aegerion pharmaceuticals inc (AEGR)
| Name (Connections) | Board Relationships | Title | Type of Board Member | Age |
| Marc Beer | 65 Relationships | Chief Executive Officer and Director | -- | 47 |
Other Board Members on Board*
| Name (Connections) | Board Relationships | Type of Board Member | Primary Company | Age |
| David Scheer | 44 Relationships | -- | Tengion, Inc. | 59 |
| Antonio Gotto Jr., M.D., D.Phil. | 85 Relationships | -- | Aegerion Pharmaceuticals, Inc. | 76 |
| John Kastelein M.D., Ph.D. | 111 Relationships | -- | AtheroNova Inc. | 58 |
| Sol Barer Ph.D. | 177 Relationships | -- | BioNJ Inc. | 65 |
| Paul Thomas | 32 Relationships | -- | Roka Bioscience, Inc. | 56 |
| Willis Maddrey M.D., M.A.C.P., F.R.C.P. (London) | 162 Relationships | -- | University of Texas Southwestern Medical Center - Dallas | -- |
| Daniel Rader M.D., FAHA | 86 Relationships | -- | Vascular Strategies LLC | -- |
| James McKenney Pharm.D | 13 Relationships | -- | National Clinical Research, Inc. | -- |
| Jay Horton M.D. | 13 Relationships | -- | Aegerion Pharmaceuticals, Inc. | -- |
| Frank Sacks M.D. | 13 Relationships | -- | Aegerion Pharmaceuticals, Inc. | -- |
| David Cohen M.D., Ph.D. | 13 Relationships | -- | Aegerion Pharmaceuticals, Inc. | -- |
| Sandford Smith | 57 Relationships | -- | Tullis Health Investors Inc. | 64 |
| Anne VanLent | 57 Relationships | -- | Biota Pharmaceuticals, Inc. | 64 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| AEGR:US | $60.29 USD | +0.18 |  |
| Company | Last | Change | |
| No competitor information is available for AEGR. | |||
| View Industry Companies | |||
Industry Analysis
AEGR
Industry Average
| Valuation | AEGR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1,417.3x |
|
| Price/Book | 14.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1,318.8x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
